# Safety and Pharmacokinetics of IMT504, an Immunomodulator and Tissue Repair Inducer

> **NCT06312423** · PHASE1 · UNKNOWN · sponsor: **Ministry of Public Health of the Province of La Rioja** · enrollment: 12 (estimated)

## Conditions studied

- Immune System

## Interventions

- **DRUG:** Oligonucleotides, Phosphorothioate

## Key facts

- **NCT ID:** NCT06312423
- **Lead sponsor:** Ministry of Public Health of the Province of La Rioja
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-23
- **Primary completion:** 2024-08-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2024-03-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06312423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06312423, "Safety and Pharmacokinetics of IMT504, an Immunomodulator and Tissue Repair Inducer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06312423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*